Table 2. NIH Funding for 2008 and 2019 and Proportion of Total NIH Funding.
Disease category | NIH spending, No. (%), $ (in millions) | Change % | |
---|---|---|---|
2008 (N = 37 735)a | 2019 (N = 39 420) | ||
Total | 21 512 (57.0) | 23 680 (60.1) | 10 |
Infection | |||
Total | 4438 (11.8) | 4075 (10.3) | –8 |
HIV/AIDS | 3770 (10.0) | 3037 (7.7) | –19 |
STIs, excluding HIV | 315 (0.8) | 354 (0.9) | 12 |
Tuberculosis | 183 (0.5) | 488 (1.2) | 167 |
Malaria | 170 (0.5) | 196 (0.5) | 15 |
GI | |||
Total | 2924 (7.7) | 3336 (8.5) | 14 |
Digestive diseases | 1836 (4.9) | 2173 (5.5) | 18 |
Chronic kidney disease | 673 (1.8) | 649 (1.6) | –4 |
Cirrhosis | 310 (0.8) | 351 (0.9) | 13 |
Inflammatory bowel disease | 104 (0.3) | 163 (0.4) | 56 |
Other | |||
Total | 2792 (7.4) | 3125 (7.9) | 12 |
Urologic diseases | 687 (1.8) | 546 (1.4) | –21 |
Injuries | 597 (1.6) | 897 (2.3) | 50 |
Oral disorders | 596 (1.6) | 613 (1.6) | 3 |
Perinatal disordersb | 578 (1.5) | 784 (1.9) | 36 |
Interpersonal violence | 236 (0.6) | 141 (0.4) | –40 |
Self-harm | 50 (0.1) | 117 (0.3) | 133 |
Sudden infant death syndrome | 37 (0.1) | 11 (<0.1) | –71 |
Psoriasis | 10 (<0.1) | 16 (<0.1) | 55 |
Cardiovascular | |||
Total | 2610 (6.9) | 2394 (6.1) | –8 |
Ischemic heart disease | 1567 (4.2) | 1443 (3.7) | –8 |
Other cardiovascular diseases | 704 (1.9) | 685 (1.7) | –3 |
Hypertension | 339 (0.9) | 266 (0.7) | –21 |
Mental health | |||
Total | 2557 (6.8) | 3056 (7.8) | 20 |
Drug use disorders | 1296 (3.4) | 1621 (4.1) | 25 |
Alcohol use disorders | 582 (1.5) | 556 (1.4) | –4 |
Depressive disorders | 518 (1.4) | 578 (1.5) | 12 |
Autism | 152 (0.4) | 290 (0.7) | 91 |
Eating disorders | 9 (<0.1) | 11 (<0.1) | 22 |
Cancer | |||
Total | 2545 (6.7) | 2560 (6.5) | 1 |
Breast cancer | 935 (2.5) | 709 (1.8) | –24 |
Prostate cancer | 373 (1.0) | 263 (0.7) | –30 |
Colon and rectum cancer | 353 (0.9) | 294 (0.7) | –17 |
Non-Hodgkin lymphoma | 248 (0.7) | 248 (0.6) | 0 |
Lung cancer | 218 (0.6) | 419 (1.1) | 93 |
Ovarian cancer | 124 (0.3) | 168 (0.4) | 36 |
Liver cancer | 115 (0.3) | 127 (0.3) | 11 |
Cervical cancer | 89 (0.2) | 106 (0.3) | 19 |
Leukemia | 50 (0.1) | 178 (0.5) | 255 |
Hodgkin lymphoma | 21 (0.1) | 12 (<0.1) | –42 |
Uterine cancer | 21 (0.1) | 36 (0.1) | 75 |
Neurologic | |||
Total | 1701 (4.5) | 3451 (8.8) | 103 |
Alzheimer and dementias | 530 (1.4) | 2398 (6.1) | 352 |
Stroke | 381 (1.0) | 350 (0.9) | –8 |
Schizophrenia | 321 (0.8) | 263 (0.7) | –18 |
Multiple sclerosis | 218 (0.6) | 111 (0.3) | –49 |
Parkinson disease | 196 (0.5) | 224 (0.6) | 14 |
Motor neuron disease | 55 (0.1) | 105 (0.3) | 90 |
Endocrine | |||
Total (diabetes) | 1390 (3.7) | 1099 (2.8) | –21 |
Respiratory | |||
Total | 533 (1.4) | 571 (1.4) | 7 |
Asthma | 317 (0.8) | 313 (0.8) | –1 |
Pneumonia | 120 (0.3) | 146 (0.4) | 22 |
COPD | 97 (0.3) | 112 (0.3) | 16 |
Sensory | |||
Total (otitis media) | 23 (0.1) | 13 (<0.1) | –44 |
Abbreviations: COPD, chronic obstructive pulmonary disease; GI, gastrointestinal; STI, sexually transmitted infection.
Adjusted to 2019 dollars.
Includes neonatal disorders.